Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleConsolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 224
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07014202 - No phaseNot yet taking people in KínaEfficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC
- Where
- Fuzhou
- Életkor
- 18 év and over
- People
- 35
- Run by
- Fuzhou General Hospital
See details and how to joinNCT07093762 - 2. fázisTaking peoplePerioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
- Where
- Changsha, Xi'an, Yinchuan
- Életkor
- 18 év and over
- People
- 27
- Run by
- Tang-Du Hospital
See details and how to joinNCT06864624 - 2. fázisTaking peopleTislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer:A Prospective, Single-Arm, Phase II Study
- Where
- Zibo
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Zibo Municipal Hospital
See details and how to joinNCT07085182 - No phaseTaking peopleElectroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC
- Where
- Tianjin
- Életkor
- 65 év to 100 év
- People
- 120
- Run by
- Kong Fanming
See details and how to joinNCT07086300 - 2. fázisNot yet taking people in KínaA Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
- Where
- Beijing, Changsha, Hangzhou, Shanghai, Xi’an
- Életkor
- 18 év and over
- People
- 164
- Run by
- Yang Fan, MD
See details and how to joinNCT07086326 - 2. fázisTaking peopleCombination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT07086456 - 1/2. fázisTaking peoplePhase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
- Where
- Baoding, Baotou, Beijing, Dalian, Neimeng, Tianjin
- Életkor
- 18 év and over
- People
- 42
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07087223 - 3. fázisTaking peopleNeoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 497
- Run by
- Sun Yat-sen University
See details and how to joinNCT06734702 - No phaseTaking peopleAcupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer
- Where
- Beijing, Changsha, Hefei
- Életkor
- 18 év to 75 év
- People
- 240
- Run by
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT06926140 - 2. fázisNot yet taking people in KínaA Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 56
- Run by
- Zhijie Wang
See details and how to joinNCT07083375 - 2. fázisTaking peopleA Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Sichuan University
See details and how to joinNCT06951464 - 3. fázisTaking peopleHypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
- Where
- Chongqing, Guangzhou, Lanzhou
- Életkor
- 18 év to 75 év
- People
- 311
- Run by
- Sun Yat-sen University
See details and how to joinNCT07052669 - 2. fázisTaking peoplePemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 105
- Run by
- Fudan University
See details and how to joinNCT04136535 - 2. fázisTaking peopleA Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 427
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT06947694 - No phaseTaking peopleReal-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07008287 - No phaseTaking peopleTransthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer
- Where
- Chengdu, Guangzhou, Hangzhou, Shanghai, Zhengzhou
- Életkor
- 18 év and over
- People
- 110
- Run by
- Jiayuan Sun
See details and how to joinNCT06572540 - No phaseTaking peopleTransbronchial MWA for Pulmonary Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 15
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06969014 - 2. fázisTaking peopleAfatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shandong Public Health Clinical Center
See details and how to joinNCT06709859 - No phaseTaking peopleSmall Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 45 év to 80 év
- People
- 38
- Run by
- Shanghai Chest Hospital of Shanghai Jiao Tong University
See details and how to joinNCT07070011 - 2. fázisTaking peopleA Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
- Where
- Beijing, Binzhou, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guilin, Hangzhou, Harbin, Hefei, Jinan, Lanzhou, Linyi, Shenyang, Shijiazhuang, Taiyuan, Taizhou, Tianjin, Wuhan, Xiangyang, Yibin, Yiyang, Yueyang, Yunnan, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06962865 - 2. fázisTaking peopleTislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Hua Zhang
See details and how to joinNCT06617936 - No phaseTaking peopleAn Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT05486650 - No phaseTaking peopleEfficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT05754203 - 1. fázisTaking peoplePhase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 101
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06128148